Hepatocellular carcinoma in patients with chronic hepatitis C – case study
DOI:
https://doi.org/10.12775/JEHS.2022.12.03.019Keywords
hepatocellular carcinoma, HCV infection, complications of hepatitis CAbstract
Introduction. In Poland, approximately 2% of the total population is infected with hepatitis C virus (HCV) (estimated at 730,000 people). HCV is an etiologic factor of chronic hepatitis C. Hepatitis C is a chronic disease which, when untreated, may lead to cirrhosis of the liver and/or primary liver cancer.
Objective. The aim of the study was analysis of the personal medical history of a patient with hepatocellular cancer from the aspect of infection with HCV.
Material and Method. A case of a 63-year-old patient is presented with the diagnosis of hepatocellular carcinoma (HCC) (Carcinoma hepatocellulare), who had undergone the procedure of thermal ablation of the pathological change in the liver. The patient was treated with chemotherapy on a daily basis; anti-HCV antibodies were detected. The research method was a retrospective case study; the technique – analysis of records (internal documentation of the Regional Hospital in Pionki, Poland; while the research tools – medical history with the results of diagnostic tests, the VAS scale and the Glasgow scale.
Results. Based on internal documentation of the hospital a case of a patient was described with severe abdominal pain due to hepatocellular carcinoma, who had been previously diagnosed with HCV infection. Physical examination was presented, as well as epidemiological interview, medical history, the course of diagnostics and treatment of the patient qualified for further ambulatory treatment in the oncology outpatient clinic.
Conclusions. Screening examinations are indicted for an early detection of the presence of anti-HCV antibodies. An early diagnosis of infection with HCV, and implementation of antiviral treatment may prevent the development of hepatocellular carcinoma.
References
Klamann J, Smiatacz T.: Diagnostyka wirusowych zapaleń wątroby w praktyce lekarza pierwszego kontaktu. For Med Rodz 2016; 10(2): 67-71.
Jeziorski A, Rutkowski P, Wysocki W.: Chirurgia onkologiczna - tom 3. Wydawnictwo Lekarskie PZWL, Warszawa 2021, 1057-1086.
Krawczyk M, Wasilewicz MP, Hartleb M (red.): Rozpoznawanie i leczenie raka wątrobowokomórkowego - rekomendacje Sekcji Hepatologicznej Polskiego Towarzystwa Gastroenterologii. Gastroentorologia Kliniczna 2015; 7(3): 65-89.
Małkowski P, Pacholczyk M., Łagiewska B. (red.): Rak wątrobowokomórkowy — epidemiologia i leczenie. Przegl. Epidemiol. 2006; 60: 731-740.
Crissien AM, Frenette C.: Current management of hepatocellular carcinoma. Gastroenterol Hepatol 2014; 10: 153-161.
Gaillard M, Tranchart H, Dagher I.: Laparoscopic liver resections for hepatocellular carcinoma: current role and limitations. World J Gastroenterol. 2014; 20: 4892-4899.
Liu Y, Li S, Wan X. (et. al.): Efficacy and safety of thermal ablation in patients with liver metastases. Eur J Gastroenterol Hepatol 2013; 25(4): 442-446.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Lidia Sierpińska, Sebastian Jaworski
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 470
Number of citations: 0